CRISPR activation of the ribosome-associated quality control factor ASCC3 ameliorates fragile X syndrome phenotypes in mice | Science Translational Medicine
The FMRP-ASCC3 axis regulates collided ribosomes, and ASCC3 is reduced in fragile X syndrome, suggesting an alternative approach to treat the disease.